Soru

Zorluk: ZorInfectious Diseases

A 76-year-old woman is evaluated in the hospital on day 5 of her admission due to an episode of hypotension and altered mental status. She was initially admitted for a severe COPD exacerbation and has been receiving systemic glucocorticoids, nebulized bronchodilators, and prophylactic enoxaparin. An indwelling Foley catheter was placed on admission due to urinary retention and has remained in place.

Today (Day 5), her temperature is 38.3∘C38.3^\circ\text{C} (100.9∘F100.9^\circ\text{F}), blood pressure is 88/56 mmHg88/56\text{ mmHg}, heart rate is 112/min112\text{/min}, and respiratory rate is 22/min22\text{/min}. Physical examination reveals a lethargic patient. The abdomen is soft and non-tender, and there is no costovertebral angle tenderness. Laboratory findings show a leukocyte count of 16,500/mm316,500\text{/mm}^3. A urinalysis obtained from the Foley catheter port shows 25 WBCs/hpf25\text{ WBCs/hpf} and positive leukocyte esterase, but negative nitrites.

Blood and urine cultures are drawn. The patient receives intravenous fluid resuscitation, and empiric intravenous vancomycin and cefepime are initiated.

Two days later (Day 7), the patient is clinically improved, her mental status has returned to baseline, she is hemodynamically stable off fluids, and she is afebrile. Blood cultures show no growth at 48 hours. The urine culture grows >105 CFU/mL>10^5\text{ CFU/mL} of *Enterococcus faecalis*.

Antimicrobial susceptibility testing for the *E. faecalis* isolate demonstrates the following:
- Ampicillin: Susceptible
- Cefepime: Resistant
- Ciprofloxacin: Resistant
- Linezolid: Susceptible
- Vancomycin: Susceptible

Which of the following is the most appropriate next step in the antimicrobial management of this patient?

  1. A
    Discontinue cefepime and continue intravenous vancomycin
  2. B
    Continue both intravenous vancomycin and cefepime
  3. Discontinue vancomycin and cefepime, and initiate intravenous ampicillinCevap
  4. D
    Discontinue vancomycin and cefepime, and initiate oral linezolid
  5. E
    Discontinue all antimicrobial therapy and recommend removal of the Foley catheter

Cevap

Discontinue vancomycin and cefepime, and initiate intravenous ampicillin
The correct answer is to discontinue vancomycin and cefepime, and initiate intravenous ampicillin. This patient presented with a catheter-associated urinary tract infection (CA-UTI) that progressed to sepsis. Her clinical improvement confirms successful empiric therapy. *Enterococcus* species are intrinsically resistant to cephalosporins (including cefepime). While her infection responded to vancomycin, continuing it when the isolate is susceptible to ampicillin violates antimicrobial stewardship principles. Ampicillin is a bactericidal beta-lactam and is the preferred, narrower-spectrum drug of choice for ampicillin-susceptible *E. faecalis*. De-escalating to ampicillin reduces the risk of selecting for vancomycin-resistant enterococci (VRE) and other highly resistant flora.

Adım Adım Çözüm

1
Analyze the clinical presentation and initial course.
The patient developed sepsis (fever, hypotension, altered mental status, leukocytosis) due to a catheter-associated urinary tract infection (CA-UTI) and improved on empiric broad-spectrum therapy.
Establishes that this is a true, symptomatic infection requiring a full course of antimicrobial therapy, not merely asymptomatic bacteriuria.
2
Interpret the microbiological and susceptibility data.
The pathogen is *Enterococcus faecalis*. It is intrinsically resistant to cefepime, but susceptible to ampicillin, vancomycin, and linezolid.
Identifies the causative organism and the potential therapeutic options for targeted treatment.
3
Apply antimicrobial stewardship principles to select the optimal definitive therapy.
Ampicillin is selected to replace vancomycin and cefepime.
De-escalating to the narrowest-spectrum, most bactericidal agent (ampicillin) is the standard of care to maximize efficacy and prevent the emergence of vancomycin-resistant enterococci (VRE).

Anahtar Kavram

Antimicrobial stewardship in proven *Enterococcus faecalis* infections requires prompt de-escalation from empiric broad-spectrum agents (e.g., vancomycin) to a targeted, narrow-spectrum beta-lactam (e.g., ampicillin) if the isolate is susceptible.
Bu soruyu puanla